Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) is gaining momentum. The drugmaker has substantially outperformed the broader market in the past year, and it is showing few signs of slowing down. Vertex's performance is especially commendable considering the world's economic issues such as inflation.

But how long can it keep going? Can the biotech continue delivering market-beating returns in the coming 12 months? To answer that question, let's look into the many things Vertex Pharmaceuticals has going on right now.

Continue reading

Source Fool.com